Clinical Trial Update: T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a T cell receptor–based immunotherapy for patients with metastatic non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Adenosquamous Carcinoma
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• T cell receptor immunotherapy (TCR-T) (TCR-T)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Non-Small Cell Lung Cancer, Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING